Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3Ovarian Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Neoplasms 2Multiple Myeloma 2Melanoma 2Glioma 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thyroid Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Peritoneal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain 1Monoclonal Gammopathy of Undetermined Significance 1Magnetic Resonance Imaging 1Lymphoma, Follicular 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Kidney Neoplasms 1Hypothyroidism 1Hyperphagia 1Hepatic Encephalopathy 1Hematologic Neoplasms 1Head and Neck Neoplasms 1

Interventions

durvalumab 2Radiotherapy 2Etoposide 2Drug Therapy 2Cisplatin 2trilaciclib 1tislelizumab 1pamiparib 1anlotinib 1Tirapazamine 1Surgical Procedures, Operative 1Sodium Chloride 1Radiation Dose Hypofractionation 1Radiation 1Probiotics 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Glucose 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Limited Stage Small Cell Lung Cancer × Glucose × Clear all
NCT07473128 2026-03-16

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Pharmacosmos A/S

Phase 3 Not yet recruiting
120 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡